Aline Moulin graduated from the National Graduate Chemistry School of Montpellier (France) and received her MSc in Biomolecular Chemistry from the University of Montpellier in 2004. She then achieved her PhD at the Institut des Biomolécules Max Mousseron in Montpellier. She was appointed Medicinal Chemistry Research Scientist in 2007 at Sanofi Research Center (Vitry sur Seine, France).
Dr Moulin joined the R&D team of Flamel Technologies (now Avadel Pharmaceuticals, Venissieux, France) in 2009 to work on the design, development and industrialisation of drug delivery systems. In 2018, she joined Skyepharma as Senior Project Manager and was appointed Pharmaceutical Development Director in 2020.